Hindustan Bio Sciences Ltd. reported unaudited earnings results for the third quarter and nine months ended December 31, 2012. For the quarter, the company reported income from operations of INR 9.2 million against INR 2.6 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 2.8 million against INR 2.2 million a year ago. Loss from ordinary activities before tax was INR 2.8 million against INR 2.3 million a year ago. Net loss was INR 2.8 million or INR 0.28 per basic and diluted share against INR 2.3 million or INR 0.22 per basic and diluted share a year ago.

For the nine months, the company reported income from operations of INR 25.7 million against INR 18.0 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 6.0 million against INR 1.8 million a year ago. Loss from ordinary activities before tax was INR 6.2 million against INR 2.0 million a year ago. Net loss was INR 6.2 million or INR 0.60 per basic and diluted share against INR 2.0 million or INR 0.20 per basic and diluted share a year ago.